首页 | 本学科首页   官方微博 | 高级检索  
     


First report of c. 1499G>C mutation in a 6-month-child with cystic fibrosis
Authors:Abbas Sahami  Nourkhoda Sadeghifard  Alireza Monsef  Hadi Peyman
Affiliation:1.Department of Medical Genetic and Embryology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran;2.Department of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran;3.Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran;4.Department of Pathology, Hamadan University of Medical Sciences, Hamadan, Iran;5.Research Center for Prevention of Psychosocial Injuries, Ilam University of Medical Sciences, Ilam, Iran
Abstract:So far, more than 1800 mutations identified in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. In this case report, we presented first report of c. 1499G>C mutation in a 6-month-old girl with cystic fibrosis (CF) diagnosis. A 6-month-old girl with weakness and meconium Ileus referred to the pediatric clinic in Ilam, in the west of Iran. Patient''s skin was dark and suffered from bronchiectasis. The sweat test was performed, and the concentration of chloride and sodium in patient''s sweat was 130-135 mmol/L and 125-128 mmol/L, respectively. The exon 10 mutation analysis of a CF patient was performed. CFTR mutation analysis revealed the identification of 2 mutations in patient, the mutations were p.F508del (ΔF508) and c. 1499G>C (cd500), respectively. The mutation c. 1499G>C (cd500) were found for the first time in the world. Assessing this mutation in future study and genetic investigation is recommended.
Keywords:c. 1499G>  C, cystic fibrosis, cystic fibrosis transmembrane conductance regulator, direct sequencing, Iran, mutations
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号